rs6805869

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018115.3(FANCD2):​c.2976+36T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 1,369,982 control chromosomes in the GnomAD database, including 23,785 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 5016 hom., cov: 31)
Exomes 𝑓: 0.17 ( 18769 hom. )

Consequence

FANCD2
NM_001018115.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.354
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-10078233-T-C is Benign according to our data. Variant chr3-10078233-T-C is described in ClinVar as [Benign]. Clinvar id is 257077.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.414 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCD2NM_001018115.3 linkc.2976+36T>C intron_variant Intron 30 of 43 ENST00000675286.1 NP_001018125.1 Q9BXW9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCD2ENST00000675286.1 linkc.2976+36T>C intron_variant Intron 30 of 43 NM_001018115.3 ENSP00000502379.1 Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34296
AN:
151858
Hom.:
5011
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.420
Gnomad AMI
AF:
0.268
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.151
Gnomad EAS
AF:
0.0658
Gnomad SAS
AF:
0.164
Gnomad FIN
AF:
0.116
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.162
Gnomad OTH
AF:
0.194
GnomAD3 exomes
AF:
0.169
AC:
42501
AN:
251368
Hom.:
4358
AF XY:
0.167
AC XY:
22621
AN XY:
135862
show subpopulations
Gnomad AFR exome
AF:
0.433
Gnomad AMR exome
AF:
0.158
Gnomad ASJ exome
AF:
0.158
Gnomad EAS exome
AF:
0.0657
Gnomad SAS exome
AF:
0.181
Gnomad FIN exome
AF:
0.120
Gnomad NFE exome
AF:
0.159
Gnomad OTH exome
AF:
0.159
GnomAD4 exome
AF:
0.168
AC:
204163
AN:
1218006
Hom.:
18769
Cov.:
17
AF XY:
0.167
AC XY:
103477
AN XY:
618242
show subpopulations
Gnomad4 AFR exome
AF:
0.427
Gnomad4 AMR exome
AF:
0.162
Gnomad4 ASJ exome
AF:
0.156
Gnomad4 EAS exome
AF:
0.0566
Gnomad4 SAS exome
AF:
0.185
Gnomad4 FIN exome
AF:
0.123
Gnomad4 NFE exome
AF:
0.165
Gnomad4 OTH exome
AF:
0.174
GnomAD4 genome
AF:
0.226
AC:
34330
AN:
151976
Hom.:
5016
Cov.:
31
AF XY:
0.220
AC XY:
16369
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.419
Gnomad4 AMR
AF:
0.156
Gnomad4 ASJ
AF:
0.151
Gnomad4 EAS
AF:
0.0658
Gnomad4 SAS
AF:
0.165
Gnomad4 FIN
AF:
0.116
Gnomad4 NFE
AF:
0.162
Gnomad4 OTH
AF:
0.194
Alfa
AF:
0.189
Hom.:
597
Bravo
AF:
0.240
Asia WGS
AF:
0.126
AC:
440
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group D2 Benign:2
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Feb 11, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
5.9
DANN
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6805869; hg19: chr3-10119917; COSMIC: COSV55037214; COSMIC: COSV55037214; API